2019-000836-24: Immune responses to influenza and pneumococcal conjugate vaccines in older adults compared to middle-aged adults and adults. Afweerreacties tegen influenza en pneumokokken vaccin vergeleken tussen 3 leeftijdsgroepen |
|
|
| Not yet recruiting | 4 | 385 | Europe | EU/1/09/590, Suspension for injection in pre-filled syringe, Dispersion for injection, Prevenar-13 | National Institute of Health and the Environment, Innovative Medicines Initiative | Healthy volunteers above 25 years of age, Healthy volunteers above 25 years of age, Body processes [G] - Immune system processes [G12] | | | | |
2019-002585-12: Study to Assess the Immune Response and the Safety Profile of DTaP-IPVHB- PRP~T Combined Vaccine Given Concomitantly or Sequentially with 4CMenB Vaccine in Italian Infants Studio per valutare la risposta immunitaria e il profilo di sicurezza del vaccino combinato DTaP-IPVHB- PRP ~ T somministrato in concomitanza o in sequenza con il vaccino 4CMenB in infanti italiani |
|
|
| Ongoing | 4 | 396 | Europe | NA, [NA], Suspension for injection, Suspension for injection in pre-filled syringe, Hexyon sospensione iniettabile - vaccino coniugato (adsorbito) contro difterite, tetano, pertosse (componente acellulare), epatite B (rDNA), poliomielite (inattivato) ed Haemophilus influenzae di tipo b, Bexsero sospensione iniettabile in siringa preriempita - Vaccino contro il meningococco di gruppo B (rDNA, componente, adsorbito), Prevenar 13 sospensione iniettabile - Vaccino pneumococcico polisaccaridico coniugato (13 valente adsorbito) | SANOFI PASTEUR, Sanofi Pasteur, Sanofi Pasteur | Haemophilus influenzae type b immunisation Immunizzazione Haemophilus influenzae di tipo B, Active immunization against diphtheriae, tetanus, pertussis, hepatitis B, poliomyelitis & invasive infections caused by Haemophilus influenzae type b Immunizzazione attiva contro difterite, tetano, pertosse, epatite B, poliomielite e infezioni invasive causate da Haemophilus influenzae di tipo b, Diseases [C] - Virus Diseases [C02] | | | | |
| Recruiting | 4 | 516 | Europe | PPV23, pneumovax, PCV13, prevenar, Saline for injection | Liverpool School of Tropical Medicine, Pfizer | Streptococcus Pneumonia | 07/23 | 12/23 | | |
NCT04080531: Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders |
|
|
| Completed | 4 | 165 | US | Pneumococcal 13-valent Conjugate Vaccine, PCV13, Prevnar 13, Trivalent Influenza Vaccine, Flu shot, Flu vaccination, Fluzone, Fluzone HD, Fluzone High-dose, Influenza Vaccine, Influenza Virus Vaccine, Trivalent, Types A and B, TIV | Emory University, Sanofi, National Institutes of Health (NIH), National Cancer Institute (NCI) | Plasma Cell Neoplasm | 05/21 | 12/22 | | |
